Insulet
PODD
#1086
Rank
C$28.25 B
Marketcap
C$401.37
Share price
-1.42%
Change (1 day)
6.27%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): C$0.51 Billion

According to Insulet's latest financial reports the company's current earnings are C$2.52 Billion. In 2024 the company made an earning of C$0.47 Billion, an increase over its 2023 earnings that were of C$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.51 B8.55%
2024 C$0.47 B36.76%
2023 C$0.34 B481.9%
2022 C$59.34 M-45.24%
2021 C$0.10 B43.35%
2020 C$75.59 M18.51%
2019 C$63.78 M41.16%
2018 C$45.18 M-711.95%
2017 -C$7.39 Million-56.85%
2016 -C$17.12 Million-79.31%
2015 -C$82.74 Million63.85%
2014 -C$50.5 Million31.04%
2013 -C$38.54 Million-21.96%
2012 -C$49.38 Million
2010 -C$47.1 Million-42.38%
2009 -C$81.73 Million-33.56%
2008 -C$0.13 Billion65.93%
2007 -C$74.14 Million209.75%
2006 -C$23.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ICU Medical
ICUI
C$0.17 B-65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-C$0.29 Billion-156.35%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
C$1.34 B 168.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.60 B 8,807.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$11.20 B 2,137.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$8.82 B 1,662.44%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$30.98 B 6,087.41%๐Ÿ‡บ๐Ÿ‡ธ USA